GCT
QCOR

Galaxy Capital Trading’s QUESTCOR PHARMA INC QCOR Stock Holding History

Galaxy Capital Trading’s Portfolio QCOR Stock Details QCOR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2013
Q4 		– Sell
-5,800
Closed -$336K – 304
2013
Q3 		$336K Buy
+5,800
New +$345K 0.26% 142

Other funds holding QCOR

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
BC
Broadwood Capital New York $1.42B AUM 34.72% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
LSV Asset Management
LSV Asset Management Chicago, Illinois $46.4B AUM 27.74% 1-Year Est. Return
TCIM
TIAA CREF Investment Management New York $141B AUM 14.18% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return

Galaxy Capital Trading's QCOR Position: Q4 2013 in Review

Galaxy Capital Trading sold out of QUESTCOR PHARMA INC (QCOR) in Q4 2013, closing a stake of 5,800 shares — an estimated $336K sold.

Galaxy Capital Trading first reported a position in QCOR in Q3 2013 and held it in 1 quarter. The position peaked at $336K in Q3 2013. 285 funds tracked by Wall St. Rank hold QCOR as of Q4 2013.

  • Galaxy Capital Trading reported no remaining QUESTCOR PHARMA INC position as of Q4 2013 after selling out during the quarter.
  • Galaxy Capital Trading sold 5,800 QUESTCOR PHARMA INC shares in Q4 2013, an estimated $336K.
  • Galaxy Capital Trading first reported a position in QUESTCOR PHARMA INC in Q3 2013 and held it in 1 quarter.
  • Galaxy Capital Trading's QUESTCOR PHARMA INC position peaked at $336K in Q3 2013.
  • 285 funds tracked by Wall St. Rank held QUESTCOR PHARMA INC as of Q4 2013.

Based on Galaxy Capital Trading's 13F filing for Q4 2013, filed 26 Feb 2014.